Stuart Walter Peltz - Jun 11, 2021 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: Chief Executive Officer, Director
Signature: /s/ Avraham S. Adler, attorney-in-fact
Stock symbol: PTCT
Transactions as of: Jun 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/11/2021, 06:20 PM
Next filing: Jan 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+6.24K	+37.86%	$0.00	22.7K	Jun 11, 2021	By Spouse	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+36.4K		$0.00	36.4K	Jun 11, 2021	Common Stock	36.4K	$42.95	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on June 11, 2021 that vest in four equal installments over four years, commencing on June 11, 2022.
F2	This option was granted on June 11, 2021, and vests over four years, with 25% of the shares underlying the option vesting on June 11, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 11, 2022.